Scientists Have Used CRISPR to Edit a Human Embryo in The US For The First Time – ScienceAlert
ScienceAlert |
Scientists Have Used CRISPR to Edit a Human Embryo in The US For The First Time
ScienceAlert One day, CRISPR could allow us to delete genes in order to eradicate genetic diseases, add in new genes in order to vastly improve various biological functions, or even genetically modify human embryos in order to create an entirely new class of humans… |
ScienceAlert |
Scientists Have Used CRISPR to Edit a Human Embryo in The US For The First Time
ScienceAlert One day, CRISPR could allow us to delete genes in order to eradicate genetic diseases, add in new genes in order to vastly improve various biological functions, or even genetically modify human embryos in order to create an entirely new class of humans… |
|
CAR-T Cell Research Has Promoted the Study of Leukemia and …
Digital Journal CAR-T is a new type of cancer immunotherapy, which extracts immune cells with the potential to attack cancer from the patient, and makes them have the “eyes” … |
STAT |
A humbling setback for an immune-revving cancer therapy underscores the many questions facing the field
STAT “There has already been a lot of criticism of all the combination cancer immunotherapy studies going on, so I’m sure those critics will only grow louder,” said Brad Loncar, an independent investor who runs a fund focused on cancer immunotherapy. “But … Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo FailsXconomy AstraZeneca shares plunge 16 percent as lung cancer study failsCNBC AstraZeneca’s lung cancer immunotherapy trial fails to meet primary endpointPharmaceutical Business Review Fortune –Yahoo Finance –AstraZeneca all 158 news articles » |
London Free Press |
Queen’s Park is giving a funding boost to London Health Sciences Centre’s stem–cell transplant program
London Free Press London Health Sciences Centre is getting a shot in the arm from the province to boost its stem–cell transplant capabilities – improving the hospital’s ability to treat complex blood cancers. The regional health-care powerhouse is one of two Ontario … |